1. Neuroscience

Satellite glia modulate sympathetic neuron survival, activity, and autonomic function

  1. Aurelia A Mapps
  2. Erica Boehm
  3. Corinne Beier
  4. William T Keenan
  5. Jennifer Langel
  6. Michael Liu
  7. Michael B Thomsen
  8. Samer Hattar
  9. Haiqing Zhao
  10. Emmanouil Tampakakis
  11. Rejji Kuruvilla  Is a corresponding author
  1. Department of Biology, Johns Hopkins University, United States
  2. Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health, United States
  3. Department of Medicine, Division of Cardiology, Johns Hopkins University, United States
https://doi.org/10.7554/eLife.74295
Share this article
Cite this article
  1. Aurelia A Mapps
  2. Erica Boehm
  3. Corinne Beier
  4. William T Keenan
  5. Jennifer Langel
  6. Michael Liu
  7. Michael B Thomsen
  8. Samer Hattar
  9. Haiqing Zhao
  10. Emmanouil Tampakakis
  11. Rejji Kuruvilla
(2022)
Satellite glia modulate sympathetic neuron survival, activity, and autonomic function
eLife 11:e74295.
https://doi.org/10.7554/eLife.74295
  2. Download BibTeX
  3. Download .RIS

Abstract

Satellite glia are the major glial cells in sympathetic ganglia, enveloping neuronal cell bodies. Despite this intimate association, the extent to which sympathetic functions are influenced by satellite glia in vivo remains unclear. Here, we show that satellite glia are critical for metabolism, survival, and activity of sympathetic neurons and modulate autonomic behaviors in mice. Adult ablation of satellite glia results in impaired mTOR signaling, soma atrophy, reduced noradrenergic enzymes, and loss of sympathetic neurons. However, persisting neurons have elevated activity, and satellite glia-ablated mice show increased pupil dilation and heart rate, indicative of enhanced sympathetic tone. Satellite glia-specific deletion of Kir4.1, an inward-rectifying potassium channel, largely recapitulates the cellular defects observed in glia-ablated mice, suggesting that satellite glia act in part via K+-dependent mechanisms. These findings highlight neuron–satellite glia as functional units in regulating sympathetic output, with implications for disorders linked to sympathetic hyper-activity such as cardiovascular disease and hypertension.

Editor's evaluation

This study covers the understudied topic of satellite glia and its impact on sympathetic neuron survival. An unexpected increase in neuronal activity was observed when satellite glia were deleted by mouse genetics. Novel roles of satellite glia in sympathetic physiology were uncovered by physiology assays. An extensive response to the reviewers, along with the addition of supporting data, was provided by the authors.

https://doi.org/10.7554/eLife.74295.sa0

Introduction

The sympathetic nervous system prepares the body for ‘fight or flight’ responses and maintains homeostasis during daily activities such as exercise, digestion, or regulation of body temperature. Post-ganglionic neurons, which reside in sympathetic ganglia and project axons to innervate diverse peripheral organs and tissues, mediate key autonomic effects, including cardiac output, metabolism, and immune function (Goldstein, 2013). Satellite glia are the major glial cells in sympathetic ganglia (Hanani, 2010; Mapps et al., 2021) and have a unique architecture in completely enveloping neuronal cell bodies (Elfvin and Forsman, 1978; Gabella et al., 1988). Each neuron and associated glia are thought to form a discrete structural and functional unit (Hanani, 2010). Despite this intimate association, the functions of satellite glial cells in the sympathetic nervous system, particularly in vivo, are vastly understudied.

Satellite glia have been largely characterized by their distinctive location and morphology in peripheral ganglia (Elfvin and Forsman, 1978; Gabella et al., 1988). Like neurons, satellite glial cells are derived from multipotent neural crest precursors and form thin cytoplasmic sheaths around cell bodies, dendrites, and synapses of sympathetic neurons, with only 20 nm of space, the width of a synaptic cleft, between neuronal and glial membranes (Elfvin and Forsman, 1978; Gabella et al., 1988; Hanani, 2010; Pannese, 1981). Multiple satellite glia surround a single neuron and are connected with each other, and with neurons, via gap junctions, with the number of glial cells per neuron being positively correlated to soma size (Elfvin and Forsman, 1978; Hanani, 2010; Ledda et al., 2004). This unique arrangement places satellite glial cells in an ideal position to be critical regulators of neuronal connectivity, synaptic transmission, and homeostasis. Studies in sympathetic neuron–glia co-cultures have suggested roles for satellite glia in promoting dendrite growth, synapse formation, modulating extracellular ion and neurotransmitter concentrations, and regulating synaptic transmission (Enes et al., 2020; Feldman-Goriachnik et al., 2018; Hanani, 2010; Tropea et al., 1988). Satellite glia also envelop neuronal cell bodies in sensory ganglia in the peripheral nervous system (PNS) (Hanani and Spray, 2020). Recent studies implicate sensory satellite glia in regulating chronic pain through modulating neuronal hyper-excitability (Kim et al., 2016), and in promoting axon regeneration after peripheral nerve injury in vivo (Avraham et al., 2020). Satellite glia have been proposed to be closest to astrocytes in the central nervous system (CNS) with respect to expression of machinery related to neurotransmitter uptake/turnover, inward-rectifying potassium channels, functional coupling via gap junctions, and close association with synapses (Hanani and Spray, 2020; Hanani and Verkhratsky, 2021). In contrast to the wealth of information on CNS astrocytes and emerging evidence of the significance of sensory satellite glia in the PNS, little is known about the functions of satellite glia in the sympathetic nervous system in vivo.

Here, using genetic ablation in mice, we reveal that loss of satellite glia results in impaired metabolic signaling, soma atrophy, reduced expression of noradrenergic enzymes, and enhanced apoptosis of adult sympathetic neurons. The persisting neurons, however, show elevated activity as revealed by increased neuronal c-Fos expression. Consistently, satellite glia-ablated mice had enhanced circulating norepinephrine (NE) and elevated heart rate, indicative of heightened sympathetic tone. We further deleted Kir4.1, an inward-rectifying potassium channel, specifically in satellite glia in mice. Satellite glia-specific deletion of Kir4.1 largely recapitulates the cellular phenotypes observed in glia-ablated mice, suggesting that satellite glia support neurons, in part, via K+-dependent mechanisms. These findings reveal that satellite glia provide critical metabolic and trophic support to sympathetic neurons and are modulators of the ganglionic milieu, neuronal activity, and resulting autonomic behaviors.

Results

Inducible ablation of satellite glia using BLBP:iDTA mice

Fabp7, which encodes for brain lipid binding protein (BLBP), a fatty acid transporter, is one of the most highly expressed transcripts in mouse satellite glial cells (Avraham et al., 2020; Kurtz et al., 1994; Mapps et al., 2022). Using immunostaining for BLBP and tyrosine hydroxylase (TH), a marker for noradrenergic sympathetic neurons, we observed BLBP-positive satellite glia in the mouse sympathetic ganglia (superior cervical ganglia [SCG]) at both developmental and adult stages (Figure 1A). BLBP labeling was ‘patchy’ in the embryonic and neonatal ganglia, a period when satellite glia undergo migration into the ganglia and are also proliferating (Hall and Landis, 1992). However, by 2 weeks after birth, BLBP-positive satellite glial cells had expanded processes around neuronal cell bodies and formed thin ring-like glial sheaths around neuronal somas when observed at P31 (Figure 1A).

Figure 1 with 3 supplements see all
Download asset Open asset
DTA-mediated ablation of satellite glia in sympathetic ganglia.

(A) Satellite glial cells, immunolabeled with brain lipid binding protein (BLBP, green), progressively ensheathe sympathetic neuron cell bodies, labeled with tyrosine hydroxylase (TH, magenta) in the superior cervical ganglia (SCG) during development. Time points shown are embryonic day 16.5 (E16.5) and postnatal days P1, P14, and P31. Scale bar: 30 μm. (B) Reduced BLBP expression in BLBP:iDTA SCG relative to control ganglia at 14 days after the last tamoxifen injection (14 dpi). Scale bar: 100 μm. (C) Increased apoptosis in BLBP:iDTA SCG (outlined in red dashed line) compared to controls as detected by TUNEL labeling at 5 days post-tamoxifen injection (5 dpi). Scale bar: 100 μm. (D) Quantification of apoptotic cells in SCGs at 5 dpi from n = 4 control and 3 mutant mice. Data are means ± SEM. *p<0.05, t-test. (E) Increased apoptosis of satellite glial cells assessed by Sox10 immunostaining (green) and TUNEL labeling (red) in BLBP:iDTA sympathetic ganglia compared to control at 5 dpi. DAPI channel is shown in gray. Arrowheads indicate TUNEL+;Sox10+ cells. Scale bar: 30 µm. (F) Neuronal apoptosis is similar between BLBP:iDTA and control ganglia at 5 dpi as assessed by TrkA immunostaining (magenta) and TUNEL labeling (green). DAPI channel is shown in gray. Arrowheads indicate TUNEL+;TrkA+ neurons. Scale bar: 30 µm. (G) Quantification of TUNEL+;Sox10+ cells expressed as a % of Sox10+ cells. Data are presented as means ± SEM from n = 6 control and 4 mutant mice, **p<0.05, t-test. (H) Quantification of TUNEL+;TrkA+ cells expressed as a % of TrkA+ cells. Data are presented as means ± SEM from n = 4 mice per genotype, n.s, not significant, t-test. (I) Decreased association of Sox2-labeled satellite glia (green) with TH-positive sympathetic neurons (magenta) in BLBP:iDTA sympathetic ganglia compared to controls at 14 dpi. Arrows indicate Sox2-labeled nuclei of satellite glia associated with TH-positive sympathetic neuron cell bodies, while arrowheads indicate Sox2-labeled nuclei not abutting neuronal soma. Gain in both images has been set to the same level for a better visualization of Sox2-labeled nuclei in mutant ganglia. Scale bar: 30 μm. (J) Quantification of Sox2-positive cells in control and BLBP:iDTA SCGs at 14 dpi. Data are presented as mean ± SEM from n = 5 control and 6 mutant animals, **p<0.01, t-test. (K) TH DAB immunohistochemistry and hematoxylin staining shows fewer satellite glia nuclei (blue) associated with TH-labeled sympathetic neuron cell bodies (brown) in BLBP:iDTA ganglia at 14 dpi. Scale bar: 30 µm. (L) Quantification of glial nuclei associated with neuronal soma. Data are presented as means ± SEM from n = 6 control and 3 mutant animals, **p<0.05, t-test.

Figure 1—source data 1

Raw data for neuronal and glia apoptosis and glia cell counts.

https://cdn.elifesciences.org/articles/74295/elife-74295-fig1-data1-v3.xlsx

In the adult PNS, BLBP expression is restricted to satellite glia and is not detected in Schwann cells based on single-cell RNA-sequencing analysis and characterization of Fabp7-CreER2-driven reporter mice (Avraham et al., 2020). Using data sets from our recently published single-cell RNA-sequencing analysis of peripheral sympathetic and sensory ganglia from adult mice (postnatal days 30–45) (Mapps et al., 2022), we found that BLBP (Fabp7) is ~140-fold enriched in satellite glial cells compared to other ganglionic cell types (Figure 1—figure supplement 1A). Of note, Schwann cells are scarce in adult sympathetic ganglia compared to sensory ganglia based on single-cell RNA-sequencing analyses (Mapps et al., 2022). To further ensure the cellular specificity of BLBP, we generated genetic reporter mice by crossing Fabp7-CreER2 mice with ROSA26mEGFP mice (Muzumdar et al., 2007), which drives expression of membrane-tagged EGFP (Figure 1—figure supplement 1B). We found that tamoxifen treatment (180 mg/kg body weight for five consecutive days) in Fabp7-CreER2;ROSA26mEGFP mice resulted in m-EGFP reporter expression in satellite glia marked by Kir4.1 immunolabeling (Vit et al., 2006), but not in TH-positive sympathetic neurons, IBA1-labeled macrophages, or Pdgfrβ-labeled vascular mural cells in sympathetic ganglia (Figure 1—figure supplement 1C–F). Together, these results are consistent with previous studies (Avraham et al., 2022; Avraham et al., 2020; Avraham et al., 2021; Mapps et al., 2022) showing that BLBP is a specific marker for satellite glia in adult mice.

Next, to accomplish ablation of satellite glia, we crossed Fabp7-CreER2 mice (Maruoka et al., 2011) with ROSA26eGFP-DTA mice (Ivanova et al., 2005), where Cre drives expression of a copy of diphtheria toxin subunit A (DTA). At postnatal day 30, Fabp7-CreER2;ROSA26eGFP-DTA mice were injected with either vehicle (corn oil) or tamoxifen (180 mg/kg body weight) for five consecutive days, and all analyses were performed at 5 or 14 days post injection. By 2 weeks, we observed a drastic loss of BLBP expression in sympathetic (superior cervical) ganglia from tamoxifen-treated mice (henceforth referred to as BLBP:iDTA mice) compared to vehicle-injected control (Ctrl) mice (Figure 1B). While satellite glia in control ganglia formed characteristic ring-like structures around neuronal soma, glial organization was disrupted in mutant mice with diminished BLBP staining detected within the ganglia. To determine whether DTA expression results in cell death, we assessed apoptosis using TUNEL labeling and observed a threefold increase in TUNEL-positive cells in BLBP:iDTA sympathetic ganglia compared to controls at 5 days post-tamoxifen injection (Figure 1C and D). To identify cell types undergoing apoptosis, we performed TUNEL labeling together with immunostaining for Sox10, a transcription factor expressed in satellite glia (Britsch et al., 2001), and TrkA, a sympathetic neuron marker (Fagan et al., 1996). We found a twofold increase in the number of TUNEL+;Sox10+ cells in BLBP:iDTA ganglia compared to controls at 5 days post-tamoxifen injection (5 dpi) (Figure 1E–G). Although there was a trend toward enhanced neuronal apoptosis, the number of TUNEL+;TrkA+ sympathetic neurons in BLBP:iDTA ganglia was not statistically different from that in controls at this stage (Figure 1F–H). Despite increased glial apoptosis at 5 dpi, there was no significant loss of satellite glial cells at this time as assessed by quantification of Sox2-immunoreactive cells (Figure 1—figure supplement 2A and B), where Sox2 is another transcription factor expressed in satellite glia (Koike et al., 2014). However, at 5 dpi, we did observe fewer Sox2-positive glial cells juxtaposed to cell bodies of individual sympathetic neurons in mutant ganglia (Figure 1—figure supplement 2 A and C), suggesting that unhealthy/dying satellite glia lose their contacts with neuronal soma. By 14 days post-tamoxifen injection (14 dpi), however, there was a pronounced loss of Sox2-labeled satellite glial cells (54.2% decrease) in sympathetic ganglia from BLBP:iDTA mice (Figure 1I and J). To confirm ablation of Sox2-positive cells, rather than downregulated Sox2 expression in mutant ganglia, we generated binary images of Sox2-labeled cells by filtering and thresholding using ImageJ. This method allowed us to simply record the presence or absence of cells in the images in a manner independent of pixel values. Quantification of binary images revealed a substantial decrease in the number of Sox2-labeled cells (33% decrease) in BLBP:iDTA ganglia compared to controls at 14 dpi (Figure 1—figure supplement 2D and F). Of note, this 33% decrease is lower than the 54% loss quantified using Sox2 immunofluorescence (Figure 1J). Assessing binary images from the 5 dpi time point indicated that there was no significant loss of Sox2-labeled cells at this stage (Figure 1—figure supplement 2E and G), consistent with quantifications based on Sox2-immunofluorescence (see Figure 1—figure supplement 2B). As an additional measure to visualize sympathetic neurons and associated satellite glial cells in a manner that does not rely on fluorescence, we labeled sympathetic neurons using TH DAB (3,3'-diaminobenzidine) immunohistochemistry and visualized satellite glia nuclei abutting TH-positive neuronal cell bodies based on their distinctive appearance and location using hematoxylin staining. We observed a significant loss of glial nuclei associated with soma of individual sympathetic neurons in BLBP:iDTA mice compared to control mice at 14 dpi (Figure 1K and L). Together, these results indicate that satellite glia are undergoing apoptosis by 5 dpi, and by 14 dpi, there is a substantial loss of glial cells in BLBP:iDTA ganglia. Further, consistent with cell loss at 14 dpi, we found a pronounced downregulation of several satellite glia-specific transcripts, including Fabp7, Fasn, Apoe, and Kcnj10 (Mapps et al., 2022), in BLBP:iDTA sympathetic ganglia at this time as revealed by quantitative PCR (qPCR) analyses (Figure 1—figure supplement 2H).

In BLBP:iDTA ganglia, we did not find increased macrophage infiltration as assessed by quantification of IBA-1-labeled cells (Figure 1—figure supplement 3A and B). It remains to be determined whether satellite glia loss triggers increased macrophage reactivity or phagocytosis. Further, EdU labeling indicated that satellite glial cells do not undergo increased proliferation as a compensatory or injury-induced response after DTA expression (Figure 1—figure supplement 3C and D). Together, these results suggest that DTA-induced ablation of satellite glia is not accompanied by increased macrophage density or glial proliferation in mutant sympathetic ganglia.

Satellite glia depletion impairs noradrenergic enzyme expression, metabolism, and survival of sympathetic neurons

When performing TH immunostaining to visualize sympathetic neuron morphology, we noticed a striking downregulation of TH immunoreactivity in sympathetic neuronal cell bodies from BLBP:iDTA mice. TH is the rate-limiting enzyme in the biosynthesis of NE, the classical sympathetic neurotransmitter. qPCR analyses revealed a drastic downregulation in Th and Dopamine Beta-Hydroxylase (DBH) transcript levels, (88 and 99% decrease, respectively) (Figure 2A and B). DBH converts dopamine to NE in the NE biosynthetic pathway. Thus, satellite glia maintain noradrenergic enzymes in sympathetic neurons.

Figure 2 with 1 supplement see all
Download asset Open asset
Neuronal defects in norepinephrine (NE) biosynthesis, metabolism, and survival in satellite glia-depleted mice.

(A) Tyrosine hydroxylase (TH) expression is downregulated in BLBP:iDTA sympathetic neurons. Insets also show atrophied neuronal cell bodies in mutant ganglia compared to controls. Scale bar: 100 μm for upper panels and 30 μm for insets. (B) Transcripts for Th and DBH, key enzymes in norepinephrine biosynthesis, are decreased in BLBP:iDTA SCG relative to control ganglia. Data are presented as means ± SEM from superior cervical ganglia (SCG) collected from n = 3–4 animals per genotype. ***p<0.001, ****p<0.0001, t-test with Bonferroni–Dunn’s correction. (C) Histogram shows a greater distribution of smaller soma sizes in mutant neurons compared to controls. Results are means ± SEM from n = 6–8 animals per genotype, **p<0.01, two-way ANOVA with Bonferroni’s correction. (D) Reduced soma sizes, represented as median values for soma areas (μm2), of sympathetic neurons from BLBP:iDTA mice compared to controls at 5 dpi. Values are means ± SEM from n = 8 control and 6 mutant animals, *p<0.05, t-test. (E) Immunostaining shows reduced p-S6 levels in BLBP:iDTA ganglia. Scale bar:100 μm. (F, G) Cell counts in Nissl-stained SCG tissue sections show reduced sympathetic neuron numbers in satellite glia-depleted mice 14 dpi. Results are means ± SEM from n = 4 control and 5 mutant animals. **p<0.01, t-test.

Figure 2—source data 1

Raw data for neuronal morphology and survival.

https://cdn.elifesciences.org/articles/74295/elife-74295-fig2-data1-v3.xlsx

Using TH immunohistochemistry, we also observed pronounced atrophy of neuronal cell bodies in sympathetic ganglia after satellite glia loss (Figure 2A). Quantification of soma sizes revealed significantly reduced neuronal soma areas in satellite glia-depleted mice, with a greater distribution of smaller-sized cell bodies in mutant ganglia relative to controls (Figure 2C). Median values for soma areas are 162 ± 17 μm2 for control neurons vs 118 ± 7.1 μm2 for mutant neurons (Figure 2D). Since the PI3K/Akt/mTOR pathway is a known regulator of neuronal soma size (Kwon et al., 2006; van Diepen et al., 2009; Zhou et al., 2009), we assessed expression of key downstream effectors of the mTOR pathway, phosphorylated ribosomal protein 6 (p-S6) and phosphorylated eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1 (p-4-EBP1) (Meyuhas, 2008; Saxton and Sabatini, 2017), using immunostaining. We observed a dramatic reduction in p-S6 and p-4-EBP1 immunoreactivity in satellite glia-depleted ganglia (Figure 2E, Figure 2—figure supplement 1A). These results suggest that satellite glia promote soma growth, in part, via regulating mTOR signaling in sympathetic neurons.

Given the soma atrophy, we asked whether satellite glia ablation affects neuron survival. At 5 dpi, sympathetic neuron numbers in BLBP:iDTA mice were not significantly different from that in control littermates (12,240 ± 1514 in mutant vs. 14,200 ± 1005 in control mice) as revealed by Nissl staining and quantification of cell counts in tissue sections from SCG (Figure 2—figure supplement 1B). However, by 14 dpi, we found a marked loss of sympathetic neurons (24% decrease) in satellite glia-ablated ganglia (11,790 ± 706 mutant neurons vs. 15,460 ± 734 control neurons) (Figure 2F and G). Despite the decrease in neuronal numbers, sympathetic axon innervation was maintained in target organs in BLBP:iDTA mice, when assessed by wholemount TH immunostaining in iDISCO-cleared tissues and light sheet microscopy (Figure 2—figure supplement 1C–E). Intriguingly, TH levels in mutant axons appeared to be similar to that in controls (Figure 2—figure supplement 1C–E), despite the marked reduction in Th mRNA and protein in neuronal cell bodies residing in the ganglia (see Figure 2A and B), suggesting differential regulation of TH distribution in neuronal soma vs. axons.

Together, these results indicate that satellite glia provide trophic and metabolic support to adult sympathetic neurons and regulate noradrenergic biosynthetic machinery, specifically in neuronal cell bodies.

Sympathetic activity is elevated in satellite glia-depleted mice

Given neuronal deficits with satellite glia depletion, we sought to determine whether autonomic responses were impacted in BLBP:iDTA mice. In mammals, pupil size can serve as a noninvasive and rapid readout for autonomic function (McDougal and Gamlin, 2015). Pupil size is modulated by a balance of sympathetic vs. parasympathetic activity, with the sympathetic component regulating pupil dilation while parasympathetic activity controls pupil constriction (McDougal and Gamlin, 2015). To measure basal pupil size, control and BLBP:iDTA mice were dark-adapted for 2 days, and pupil sizes recorded for 5–10 s in the dark in non-anesthetized mice (Keenan et al., 2016). Surprisingly, despite the neuronal loss and downregulated noradrenergic biosynthetic enzymes in neuronal soma, we observed increased basal pupil areas in BLBP:iDTA mice compared to controls (Figure 3A and B). To ask whether this phenotype is due to decreased parasympathetic activity, we measured pupil constriction in response to increasing light intensities, ranging from 0.01 to 1000 lux, administered for 30 s. Light onset at 0.1 lux or higher resulted in rapid constriction with greater constrictions at higher light intensities in both BLBP:iDTA and control mice (Figure 3—figure supplement 1A). The intensity responses were virtually identical for the two groups (Figure 3—figure supplement 1A). These results suggest that parasympathetic function is intact in BLBP:iDTA mice and that the enlarged pupil areas likely reflect an increase in sympathetic tone with the loss of satellite glia.

Figure 3 with 1 supplement see all
Download asset Open asset
Elevated sympathetic activity in satellite glia-depleted mice.

(A, B) Dark-adapted BLBP:iDTA mice have increased basal pupil size compared to control littermates. Results are presented as mean ± SEM from n = 6 control and 5 mutant animals. *p<0.05, t-test. (C) BLBP:iDTA mice exhibit elevated heart rate, relative to controls. ECGs were recorded continuously in conscious mice for 7 days, although only data for fourth to seventh days after insertion of lead implants are included in the analysis. Results are presented as mean ± SEM from n = 5 control and 6 mutant animals. *p<0.05, **p<0.01, two-way ANOVA with Bonferroni’s correction. (D) Average heart rate over fourth to seventh days after lead implantation. Results are mean ± SEM from n = 5 control and 6 mutant animals. **p<0.01, t-test. (E, F) 6-Hydroxydopamine (6-OHDA) administration (150 mg/kg, i.p.) prevents elevated heart rate in BLBP:iDTA mice. Results are mean ± SEM from n = 5 control and 4 mutant animals, n.s, not significant, t-test. (G) Increased circulating norepinephrine levels in BLBP:iDTA mice. Results are mean ± SEM from n = 11 control and 13 mutant animals. *p<0.05, t-test. (H, I) Increased c-Fos-positive sympathetic neurons in mutant ganglia. Quantification of c-Fos+;TH+ sympathetic neurons as a % of total number of TH+ sympathetic neurons. Results are mean ± SEM from n = 3 control and 4 mutant animals. *p<0.05, t-test.

Figure 3—source data 1

Raw data for pupil size and heart rate in mice, NE secretion, and c-Fos expression.

https://cdn.elifesciences.org/articles/74295/elife-74295-fig3-data1-v3.xlsx

As a second and independent assessment of autonomic function, we measured heart rate and heart rate variability (HRV) using electrocardiogram (ECG) recordings in mice (Thireau et al., 2008). Increased sympathetic activity results in an accelerated heart rate and decreased HRV, defined as the variation in time intervals between consecutive heartbeats (Thireau et al., 2008). Strikingly, BLBP:iDTA mice exhibited increased heart rates (Figure 3C and D) and decreased HRV (Figure 3—figure supplement 1B) compared to controls. Tamoxifen injections had no effect on heart rate in wild-type C57BL/6J mice or control ROSA26eGFP-DTA mice that do not express Cre (Figure 3—figure supplement 1C and D).

To directly test the involvement of sympathetic neurons in the heart defect observed in BLBP:iDTA mice, we chemically ablated sympathetic nerves using 6-hydroxydopamine (6-OHDA), which selectively destroys sympathetic, but not parasympathetic or sensory nerves (Borden et al., 2013; Kostrzewa and Jacobowitz, 1974). Further, 6-OHDA does not cross the blood–brain barrier after intraperitoneal injections in adult animals, restricting its actions to the periphery (Kostrzewa and Jacobowitz, 1974). Ablation of sympathetic nerves prevented the augmented heart rate in BLBP:iDTA mice (Figure 3E and F), suggesting the dysfunction of peripheral sympathetic neurons as the primary contributor to the cardiac defect in satellite glia-ablated mice.

To understand the molecular and/or cellular basis for enhanced sympathetic activity in satellite glia-depleted mice, we measured circulating NE levels and observed a significant 1.6-fold increase in BLBP:iDTA mice compared to controls (Figure 3G). These results suggest that, despite the downregulation of NE biosynthetic machinery in neuronal cell bodies (see Figure 2A and B), neurotransmitter secretion is augmented in sympathetic axons and/or its reuptake/degradation decreased, in satellite glia-depleted mice. NE acts through α- and β-adrenergic receptors in target tissues. Heightened sympathetic activity and increased circulating NE elicits the compensatory downregulation of adrenergic receptor levels and activities in target tissues (Eschenhagen, 2008). We found significantly decreased expression of Adrb1, the major adrenergic receptor for NE signaling in the heart (de Lucia et al., 2018), as well as Adrb2 and Adra2c, using qPCR analyses of cardiac tissue (Figure 3—figure supplement 1E). Lastly, immunostaining for c-Fos, an immediate early transcription factor that serves as a reporter of neuronal activity (Sheng and Greenberg, 1990), revealed a striking eightfold increase in the number of c-Fos-positive sympathetic neurons in BLBP:iDTA ganglia compared to controls (Figure 3H and I).

Together, these results indicate that satellite glia depletion results in elevated sympathetic neuron activity, impaired NE homeostasis, and autonomic behavioral defects in mice.

Satellite glia-specific deletion of Kir4.1 disrupts sympathetic neuron activity

Kir4.1 is a glial-specific, inwardly rectifying K+ channel that shows the highest expression in astrocytes and satellite glia (Hanani and Spray, 2020; Olsen et al., 2015; Vit et al., 2008). Kcnj10 mRNA for Kir4.1 is highly enriched in satellite glia (approximately threefold enriched) compared to other ganglionic cell types based on our analysis of data sets obtained from single-cell RNA-sequencing of sympathetic and sensory ganglia from adult mice (postnatal days 30–45) (Mapps et al., 2022; Figure 4—figure supplement 1A). Co-immunolabeling for Kir4.1 and m-EGFP in Fabp7-CreER2;ROSA26mEGFP reporter mice revealed co-localization of the two signals in sympathetic ganglia (Figure 1—figure supplement 1C). Further, in BLBP:iDTA sympathetic ganglia, we observed a pronounced decrease in Kcnj10 mRNA compared to controls as assessed by qPCR analysis (Figure 1—figure supplement 2H) and single-molecule fluorescence in situ hybridization (smFISH) (Figure 4—figure supplement 1B). Our results are consistent with previous studies that Kcnj10 is enriched in satellite glial cells (Avraham et al., 2020; Hanani and Spray, 2020; Vit et al., 2008).

In mice, global or tissue-specific Kir4.1 deletion results in impaired K+ and glutamate homeostasis, loss of glial K+ conductance, neuronal excitability, epileptic seizures, and pain-like behaviors (Cui et al., 2018; Djukic et al., 2007; Olsen et al., 2015; Tang et al., 2010; Vit et al., 2008). To ask whether impaired Kir4.1 function might contribute to the neuronal defects observed in satellite glia-ablated mice, we generated satellite glia-specific Kir4.1 knockout mice (Kir4.1 cKO) by crossing Fabp7-CreER2 mice to Kcnj10 floxed mice (Djukic et al., 2007). Fabp7-CreER2; Kcnj10fl/fl (henceforth called Kir4.1 cKO) mice were treated with vehicle or tamoxifen for five consecutive days to conditionally delete Kir4.1 from satellite glial cells. Expression of Kir4.1, visualized by immunofluorescence, was significantly reduced in Kir4.1 cKO sympathetic ganglia (Figure 4A), and qPCR analysis indicated a 76% decrease in Kcnj10 transcript levels (Figure 4B).

Figure 4 with 1 supplement see all
Download asset Open asset
Satellite glia-specific Kir4.1 loss impairs norepinephrine (NE) enzyme expression and neuron activity.

(A, B) Reduced Kir4.1 protein and transcript (Kcnj10) in Kir4.1 cKO mice. Scale bar: 30 μm. Data in (B) are mean ± SEM from n = 3 animals per genotype, **p<0.01, t-test. (C, D) Sox2-positive satellite glial cell numbers are unaffected in Kir4.1 cKO SCG. Arrows indicate Sox2-labeled nuclei of satellite glia associated with sympathetic neuron cell bodies. Arrowheads indicate Sox2-labeled satellite glia that are not adjacent to neuronal soma. Scale bar: 30 μm. Data are presented as mean ± SEM from n = 3 animals per genotype, n.s., not significant, t-test. (E, F) Kir4.1 deletion in satellite glia results in an increase in c-Fos-positive sympathetic neurons. Quantification of c-Fos+;TH+ sympathetic neurons as a % of total number of TH+ sympathetic neurons. Scale bar: 100 μm. Quantifications are mean ± SEM from n = 3 animals per genotype, *p<0.05, t-test. (G, H) Downregulation of NE biosynthetic enzymes, TH and DBH, in Kir4.1 cKO sympathetic ganglia. Results are mean ± SEM from n = 3–5 animals per genotype, *p<0.05, ****p<0.0001, t-test with Bonferroni’s correction.

Figure 4—source data 1

Raw data for glia and neuron cell counts and gene expression changes in Kir4.1 mutant and control mice.

https://cdn.elifesciences.org/articles/74295/elife-74295-fig4-data1-v3.xlsx

Loss of Kir4.1 did not alter satellite glial numbers in sympathetic ganglia as assessed by quantification of Sox2-positive cells (Figure 4C and D, Figure 4—figure supplement 1C and D). Kir4.1 deletion also did not affect Fabp7 (BLBP) expression in satellite glia assessed by qPCR analysis and immunostaining (Figure 4—figure supplement 1E and F). BLBP immunostaining also indicated that the characteristic ring-like glial organization around neuronal soma was not perturbed in Kir4.1 cKO sympathetic ganglia (Figure 4—figure supplement 1F). However, we observed a marked increase in the number of c-Fos-positive cells in Kir4.1 cKO SCGs compared to controls (Figure 4E and F). The majority of c-Fos-positive cells in Kir4.1 cKO ganglia appeared to be neurons based on their morphology. Intriguingly, despite increased c-Fos-positive sympathetic neurons, Kir4.1 deletion resulted in downregulated expression of noradrenergic biosynthetic enzymes, TH and DBH, in neuronal cell bodies (Figure 4C, G, and H), similar to the phenotype observed with satellite glia depletion.

Together, these results suggest that satellite glial cells control sympathetic neuron activity and noradrenergic enzyme expression via Kir4.1-dependent regulation of the neuronal microenvironment.

Satellite glia-specific deletion of Kir4.1 elicits neuron atrophy and apoptosis

We next addressed the relevance of satellite glia Kir4.1 expression in sympathetic neuron viability. Quantification of soma sizes revealed that neurons undergo atrophy in Kir4.1 cKO sympathetic ganglia (Figure 5A), similar to the defect observed with DTA-induced loss of satellite glia. Soma areas from tissue sections, represented as median values, were 155 ± 13 μm2 for control neurons vs. 118 ± 3.6 μm2 for mutant neurons (Figure 5B). Kir4.1 loss in satellite glial cells also elicited a pronounced decrease in the levels of p-S6 and p-4-EBP1, two well-established downstream effectors of mTOR activity (Meyuhas, 2008; Saxton and Sabatini, 2017), in sympathetic neurons (Figure 5C, Figure 5—figure supplement 1A), similar to the effects of satellite glia ablation (Figure 2E, Figure 2—figure supplement 1A). Notably, we observed an eightfold increase in apoptotic cells in Kir4.1 cKO sympathetic ganglia using TUNEL labeling at 14 days post-tamoxifen injection (Figure 5D and E). The apoptotic cells were primarily sympathetic neurons based on co-labeling for TUNEL and TrkA (Figure 5—figure supplement 1B and C). We did not observe increased apoptosis of satellite glial cells in Kir4.1 cKO sympathetic ganglia compared to controls (Figure 5—figure supplement 1D and E), consistent with results that the number of Sox2-positive satellite glia was not altered by Kir4.1 deletion (see Figure 4C and D). Consistent with enhanced neuronal apoptosis, we observed a 22% decrease in sympathetic neuron numbers in Kir4.1 cKO sympathetic ganglia by 2 weeks after tamoxifen injections (Figure 5F and G). Similar to the findings in BLBP:iDTA mice, sympathetic axon innervation and axonal TH expression were similar between Kir4.1 cKO mice and controls (Figure 5—figure supplement 1F and G), despite the decrease in sympathetic neuron numbers and downregulated TH expression in neuronal cell bodies. Together, these results highlight that Kir4.1 is necessary for the survival of adult sympathetic neurons.

Figure 5 with 1 supplement see all
Download asset Open asset
Defects in neuron viability in Kir4.1 cKO mice.

(A) Kir4.1 cKO sympathetic neurons have smaller soma sizes compared to control neurons. Results are mean ± SEM from n = 3 control and 5 mutant mice, ***p<0.001, two-way ANOVA with Bonferroni’s correction. (B) Reduced soma size, represented as median values of soma areas (μm2) of Kir4.1 cKO sympathetic neurons compared to controls. Values are mean ± SEM from n = 3 control and 5 mutant animals, *p<0.05, t-test. (C) Decreased mTOR signaling based on p-S6 immunostaining in Kir4.1 cKO sympathetic ganglia. Scale bar: 100 μm. (D) TUNEL labeling shows increased apoptosis in Kir4.1 cKO SCG (outlined in red dashed line). Scale bar: 100 μm. (E) Quantification of apoptotic cells in control and mutant sympathetic ganglia from n = 3 mice per genotype. Data presented as mean ± SEM **p<0.01, t-test. (F, G) Decreased sympathetic neuron numbers in Kir4.1 cKO mice based on Nissl-staining and cell counts in sympathetic ganglia tissue sections. Results are mean ± SEM from n = 3 control and 4 mutant animals. *p<0.05, t-test. (H) Heart rate is unaffected by Kir4.1 deletion from satellite glia. Results are mean ± SEM from n = 5 control and 6 mutant animals, two-way ANOVA with Bonferroni’s correction. (I) Average heart rate over days 4–7 post-lead implantation. Results are mean ± SEM from n = 5 control and 6 mutant animals. n.s., not significant.

Figure 5—source data 1

Raw data for neuron morphology and heart rate in Kir4.1 mutant and control mice.

https://cdn.elifesciences.org/articles/74295/elife-74295-fig5-data1-v3.xlsx

We next asked whether satellite glia-specific Kir4.1 deletion recapitulates the autonomic defects observed in BLBP:iDTA mice. Measurements of basal pupil size, heart rate, and circulating NE levels indicated that these parameters were not significantly altered in Kir4.1 cKO mice (Figure 5H and I, Figure 5—figure supplement 1H–J), despite increased neuronal activity as assessed by c-Fos immunoreactivity (see Figure 4E and F). Parasympathetic activity assessed by pupil constriction in response to different light intensities was also normal in Kir4.1 cKO mice (Figure 5—figure supplement 1K).

Together, these results suggest that Kir4.1 deletion recapitulates the cellular phenotypes observed in BLBP:iDTA mice, notably, increased neuron activity, impaired metabolic signaling, and enhanced apoptosis. However, the deletion of a single gene, Kcnj10 encoding for Kir4.1, from satellite glial cells is not sufficient to drive behavioral changes at the whole animal level as seen with genetic ablation of satellite glial cells. These results suggest that there are other satellite glia-dependent mechanisms, in addition to Kir4.1 activity, that contribute to regulation of neuronal excitability to drive circuit-level changes.

Discussion

Despite decades of research on the sympathetic nervous system, satellite glia, the major glial cells in sympathetic ganglia, have remained an enigmatic component of the system. Given their specific contacts with neuronal cell bodies, satellite glia also provide the rare opportunity to study how glia support somatic compartments. Here, we show that satellite glia modulate sympathetic neuron metabolism, survival, neurotransmitter homeostasis, activity, and autonomic functions in adult mice. Together, our findings provide in vivo evidence that neurons and their surrounding glial covers are functional units in the regulation of sympathetic output.

We reveal that a key role for satellite glia is in restraining neuronal activity in mature sympathetic neurons. Depletion of satellite glia in adult mice amplifies neuronal activity, leading to increased circulating levels of NE and elevated sympathetic tone. Glia-ablated mice show enhanced pupil size and heart rate, demonstrating the necessity of these cells in the dynamic regulation of autonomic functions in conscious and freely moving animals. Our findings that satellite glia limit neuronal activity are similar to reported functions of other glial cells that encapsulate neuronal cell bodies, in particular, astrocytes (Allen and Lyons, 2018), microglia (Badimon et al., 2020; Cserép et al., 2020), and cortex glia in Drosophila (Yadav et al., 2019). Inhibitory effects of satellite glia might enable sympathetic neurons to respond to a wider range of input strengths and/or serve as a neuroprotective mechanism to limit neurotoxicity under conditions of stress or pathology.

How do satellite glia limit sympathetic neuron activity? The enhanced neuronal c-Fos signals in Kir4.1 cKO and satellite glia-ablated mice suggest that glial regulation of ion homeostasis, specifically, K+ clearance, is a key mechanism that contributes to inhibition of neuronal activity. Electrophysiological analyses show that satellite glia have high K+ conductance, which is almost exclusively dependent on Kir4.1 expression (Tang et al., 2010). Satellite glial cells are also coupled to one another through gap junctions (Huang et al., 2005; Kim et al., 2016). RNAi-mediated knockdown of Kir4.1 or Connexin 43, a gap junction protein, enhances excitability of sensory neurons and evokes nociceptive responses in rats (Ohara et al., 2008; Vit et al., 2008; Ohara et al., 2008; Vit et al., 2008). Together, these studies suggest that satellite glia are capable of taking up extracellular K+, distributing them throughout a glial syncytium via gap junction coupling, and extruding ions in regions of low K+ concentration, in a process called ‘spatial K+ buffering’ (Kuffler, 1967; Tang et al., 2010), similar to astrocyte functions in the CNS (Kofuji and Newman, 2004). Even slight elevations in extracellular K+ in the neuronal microenvironment, due to loss of glial Kir4.1, are likely to elicit neuronal depolarization and activation (Cui et al., 2018; Haydon, 2001). However, Kir4.1 may also function via additional mechanisms to modulate neuronal excitability. For example, Kir4.1 is a major contributor to the hyperpolarized resting membrane potential of satellite glia (Tang et al., 2010). Depolarization of satellite glia, induced by loss of Kir4.1, could likely affect voltage-dependent processes in these cells (Tang et al., 2010). Kir4.1, expressed in astrocytes, inhibits the synthesis of brain-derived neurotrophic factor (BDNF) in astrocytes (Kinboshi et al., 2017; Ohno et al., 2018), and astrocyte-derived BDNF has been shown to enhance neuronal activity through presynaptic mechanisms in the ventromedial hypothalamus (Ameroso et al., 2022). Thus, an analogous Kir4.1-BDNF pathway might operate in satellite glia to influence neuron activity since BDNF is known to increase presynaptic input to post-ganglionic sympathetic neurons in sympathetic ganglia (Causing et al., 1997).

We found that satellite glia-specific loss of Kir4.1 recapitulates all the cellular phenotypes observed in BLBP:iDTA sympathetic neurons, specifically, increased neuronal activity, diminished mTOR signaling, soma atrophy, downregulated expression of noradrenergic enzymes, and neuronal apoptosis. However, deletion of a single gene, Kcnj10, from satellite glia is not sufficient to drive behavioral changes at the whole animal level as accomplished by genetic ablation of these cells. Thus, additional glia-dependent mechanisms must contribute to neuronal excitability to drive network-level changes. Satellite glia could influence neuronal activity via regulation of ganglionic levels of acetylcholine, the major neurotransmitter released by pre-ganglionic axons. Despite previous observations that satellite glia modulate cholinergic neurotransmission in co-cultured sympathetic neurons (Enes et al., 2020; Feldman-Goriachnik et al., 2018), we did not detect glial transcripts involved in cholinergic signaling using single-cell RNA-sequencing of sympathetic ganglia (Mapps et al., 2022). However, we do not exclude glia-mediated effects on synapse formation during development or maintenance (Enes et al., 2020). Another potential mechanism could involve glial regulation of extracellular ATP and/or its breakdown products in the neuronal microenvironment (Hanani, 2010). In sympathetic ganglia, ATP is largely released by innervating cholinergic pre-ganglionic axons and facilitates fast excitatory neurotransmission in post-ganglionic sympathetic neurons (Boehm, 1999; Evans et al., 1992; McCaman and McAfee, 1986; Vizi et al., 1997). Extracellular ATP is rapidly metabolized by cell-surface ectonucleotidases, which are expressed in sympathetic satellite glia (Forsman and Elfvin, 1984; Nacimiento et al., 1991; Vizi et al., 1997). Single-cell RNA-sequencing data revealed several transcripts involved in ATP sensing, hydrolysis, and removal of breakdown products in sympathetic satellite glia, including the purinergic receptors, P2rx4, P2rx7, and P2ry12, and Entpd1, an ectoenzyme which catalyzes ATP to ADP hydrolysis, as well as Adk (adenosine kinase) (Mapps et al., 2022), which is best known for mediating astrocytic uptake of extracellular adenosine in the brain (Boison et al., 2010).

Our results suggest that autonomic defects observed in BLBP:iDTA mice arise primarily from defects in peripheral sympathetic neurons. We demonstrate that 6-OHDA-mediated ablation of sympathetic nerves prevents elevated heart rate in BLBP:iDTA mice. Since 6-OHDA selectively destroys sympathetic nerves (Kostrzewa and Jacobowitz, 1974), these results exclude the involvement of sensory or parasympathetic neurons to the cardiac defect in BLBP:iDTA mice. Parasympathetic function in BLBP:iDTA mice appears to be unaffected since mutant mice fully constrict their pupils in response to light. BLBP is also expressed in neuronal progenitors, radial glia, and astrocytes in the CNS (Ebrahimi et al., 2016; Feng et al., 1994; Matsumata et al., 2012). We used Fabp7-CreER2 mice in an inducible manner in adult age, which allowed us to bypass the targeting of cell types during development. Although we cannot completely exclude an astrocyte contribution to autonomic defects in BLBP:iDTA mice, our results implicate a peripheral locus given the rescue of cardiovascular dysfunction in mutant mice by 6-OHDA, which does not cross the blood–brain barrier in adult mice after intraperitoneal injections (Kostrzewa and Jacobowitz, 1974). Our single-cell RNA-sequencing analysis of satellite glia (Mapps et al., 2022) compared to published single-cell RNA studies of astrocytes (Batiuk et al., 2020) indicates an ~45-fold enrichment of Fabp7 transcript in satellite glia relative to astrocytes. Further, astrocyte ablation in adult mice results in severe motor deficits, including limb paralysis, ataxia, as well as smaller body weight (Schreiner et al., 2015), none of which were observed in BLBP:iDTA mice. Similarly, astrocyte-specific deletion of Kcnj10 using GFAP-cre mice results in premature lethality, epileptic seizures, and severe ataxia (Djukic et al., 2007), none of which were observed with Kir4.1 deletion using Fabp7-CreER2 mice. Together, these results suggest that astrocytes are minimally perturbed in BLBP:iDTA and Kir4.1 cKO mice.

In a previous study, chemogenetic manipulation of satellite glia by activating a Gq-GPCR signaling pathway increased heart rate in Gfap-hM3Dq mice (Xie et al., 2017). The experimental manipulation, that is, acute activation (over a time scale of minutes) of a Gq-GPCR pathway in satellite glia using DREADD ligands is different from that in our study (genetic ablation of these cells over 2 weeks), making it challenging to directly compare between the two studies. Also, how activation of a Gq-GPCR signaling pathway and calcium mobilization in satellite glia affects their physiology and function remains unknown. Additionally, we note that cellular specificity of the Cre driver lines used in the two studies is different. We, and others, have shown that Fabp7 (BLBP) is a specific marker for satellite glia in this study and other work (Avraham et al., 2022; Avraham et al., 2020; Avraham et al., 2021; Mapps et al., 2022). Using single-cell sequencing, we, and others, have not detected Gfap in mouse satellite glia under normal or reactive conditions (Jager et al., 2020; Mapps et al., 2022; Mohr et al., 2021), although it is found in satellite glia in rats (Mohr et al., 2021). Nevertheless, sympathetic satellite glia, very likely, exert both excitatory and inhibitory effects on neuronal activity in a context-dependent manner, similar to astrocyte functions in the brain (Allen and Lyons, 2018). Specifically, under conditions of nerve injury or inflammation, activated sensory satellite glia are known to undergo structural and functional changes, resulting in neuronal hyper-excitability (Hanani and Spray, 2020). Limited studies, so far, suggest that in response to nerve damage, sympathetic satellite glia are also capable of reactive changes, specifically, enhanced gap junction-mediated coupling and increased ATP sensitivity (Feldman-Goriachnik and Hanani, 2019), which, in turn, may augment neuronal activity.

An intriguing finding was that satellite glia depletion or glial deletion of Kir4.1 resulted in the loss of ~25% of adult sympathetic neurons. The exquisite dependence of sympathetic neurons on the target-derived survival factor, nerve growth factor (NGF), during development is well-documented (Glebova and Ginty, 2005). However, loss of NGF signaling does not compromise the survival of adult neurons (Angeletti et al., 1971; Tsui-Pierchala and Ginty, 1999), and to date, the trophic mechanisms underlying adult sympathetic neuron survival in vivo remain undefined. The similar phenotypes of soma atrophy, impaired mTOR signaling, and enhanced apoptosis in adult BLBP:iDTA and Kir4.1 cKO sympathetic neurons suggest that satellite glia provide metabolic and trophic support to mature neurons, primarily, via regulation of K+ homeostasis. Of note, astrocyte-specific Kir4.1 deletion also results in defects in mTOR signaling and decreased soma size, but not cell death, in a population of spinal cord motor neurons (Kelley et al., 2018). Whether observed apoptosis of mature sympathetic neurons in BLBP:iDTA or Kir4.1 cKO mice is linked to hyperexcitability of a vulnerable neuronal subpopulation and/or reflects the requirement for glial-derived trophic signals remain to be defined. Further, despite enhanced sympathetic neuron activity and circulating NE levels in satellite glia-ablated mice, we observed a pronounced downregulation of NE biosynthetic machinery, specifically in neuronal cell bodies. This may reflect a compensatory response to elevated sympathetic activity upon glia loss or the need for glia-derived factors in maintenance of noradrenergic enzymes. It is also notable that satellite glia depletion resulted in soma-specific effects in sympathetic neurons, that is, TH downregulation and soma size decrease, without perturbing axonal TH levels and innervation. Th mRNA is trafficked to sympathetic axons, where it is locally translated (Gervasi et al., 2016). Thus, enhanced Th mRNA trafficking and local synthesis might be a mechanism to maintain axonal TH expression and to locally regulate NE release in BLBP:iDTA sympathetic neurons.

Heightened activity of the sympathetic nervous system is a characteristic feature of several pathological conditions, specifically, chronic heart failure (Malpas, 2010), arrhythmias (Hasan, 2013; Schwartz, 2014), hypertension (Goldstein et al., 2002; Schlaich et al., 2004), sleep apnea, obesity, and insulin resistance (Mahfoud et al., 2011; Mancia et al., 2007; Schlaich et al., 2004). While sympathetic neurons, so far, have been at the center stage in considering pathological mechanisms and treatments, our study, together with other recent work (Xie et al., 2017), highlights the therapeutic potential of targeting the neuron–satellite glia unit in autonomic-related diseases.

Quantification and statistical analyses

Information for statistical analyses for all experiments is provided in ‘Materials and methods’ and figure legends.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Strain, strain background (Mus musculus)Fabp7-CreER2Maruoka et al., 2011
Strain, strain background (M. musculus)Gt(ROSA)26Sortm1(DTA)Jpmb/JThe Jackson LaboratoryRRID:IMSR_JAX:006331
Strain, strain background (M. musculus)B6.129-Kcnj10tm1Kdmc/JDjukic et al., 2007RRID:IMSR_JAX:026826
Strain, strain background (M. musculus)Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)LuoMuzumdar et al., 2007RRID:IMSR_JAX:007576
Strain, strain background (M. musculus)C57Bl/6JThe Jackson LaboratoryRRID:IMSR_JAX:000664
AntibodyAnti-BLBP (mouse monoclonal)AbcamCat# ab131137 (discontinued); RRID:AB_11157091IF (1:500)
AntibodyAnti-BLBP (rabbit polyclonal)AbcamCat# ab32423; RRID:AB_880078IF (1:200)
AntibodyAnti-Sox2 (rabbit polyclonal)Active MotifCat# 39823, RRID:AB_2793356IF (1:500)
AntibodyAnti-IBA1 (rabbit polyclonal)WAKOCat# 019-19741; RRID:AB_839504IF (1:200)
AntibodyAnti-Kir4.1 (rabbit polyclonal)Alomone LabsCat# APC-035; RRID:AB_2040120IF (1:100)
AntibodyAnti-pS6 (rabbit polyclonal)Cell SignalingCat# 2215S; RRID:AB_916156IF (1:200)
AntibodyAnti-tyrosine hydroxylase (mouse monoclonal)SigmaCat# T2928; RRID:AB_477569IF (1:300)
AntibodyAnti-tyrosine hydroxylase (rabbit polyclonal)MilliporeCat# ab152; RRID:AB_390204IF (1:300)
AntibodyAnti-c-Fos (rabbit polyclonal)AbcamCat# ab190289; RRID:AB_2737414IF (1:1000)
AntibodyAnti-Sox10 (goat polyclonal)R&D SystemsCat# AF2864; RRID:AB_442208IF (1:50)
AntibodyAnti-p-4E-BP-1 (rabbit monoclonal)Cell SignalingCat# 2855T; RRID:AB_560835IF (1:200)
AntibodyAnti-TrkA (rabbit polyclonal)MilliporeCat# 06-674; RRID:AB_310180IF (1:200)
AntibodyAmersham ECL Rabbit IgG, HRP-linked whole Ab from donkey (rabbit polyclonal)CytivaCat# NA934; RRID:AB_772206DAB (1:200)
Sequence-based reagentAdra1a TaqMan ProbeThermo FisherAssay ID: Mm00442668_m1
Sequence-based reagentAdra1b TaqMan ProbeThermo FisherAssay ID: Mm00431685_m1
Sequence-based reagentAdra1d TaqMan ProbeThermo FisherAssay ID: Mm01328600_m1
Sequence-based reagentAdra2a TaqMan ProbeThermo FisherAssay ID: Mm00845383_s1
Sequence-based reagentAdra2b TaqMan ProbeThermo FisherAssay ID: Mm00477390_s1
Sequence-based reagentAdra2c TaqMan ProbeThermo FisherAssay ID: Mm00431686_s1
Sequence-based reagentAdrb1 TaqMan ProbeThermo FisherAssay ID: Mm00431701_s1
Sequence-based reagentAdrb2 TaqMan ProbeThermo FisherAssay ID: Mm02524224_s1
Sequence-based reagentAdrb3 TaqMan ProbeThermo FisherAssay ID: Mm02601819_g1
Sequence-based reagentEukaryotic Rn18s Endogenous Control (VIC/MGB probe, primer limited)Thermo FisherCat# 4319413E
Sequence-based reagentTh_FThis paperqPCR primersAATCCACCACTTAGAGACCCG (‘Materials and methods’)
Sequence-based reagentTh_RThis paperqPCR primersCTTGGTGACCAGGTGGTGAC
(‘Materials and methods’)
Sequence-based reagentDBH_FThis paperqPCR primersCATCTGGATTCCCAGCAAGACT
(‘Materials and methods’)
Sequence-based reagentDBH_RThis paperqPCR primersCAGCGACTGAAATGGCTCTTCC
(‘Materials and methods’)
Sequence-based reagentRn18s_FCeasrine et al., 2018qPCR primersCGCCGCTAGAGGTGAAATTC
Sequence-based reagentRn18s _RCeasrine et al., 2018qPCR primersTTGGCAAATGCTTTCGCTC
Sequence-based reagentKcnj10_FHarvard Primer BankPrimerBank ID:34328498a1GTCGGTCGCTAAGGTCTATTACA
Sequence-based reagentKcnj10_RHarvard Primer BankPrimerBank ID:34328498a1GGCCGTCTTTCGTGAGGAC
Sequence-based reagentFabp7CreER2 _FMaruoka et al., 2011PCR primersTACCGGTCGACAACGAGTGATGAGG
Sequence-based reagentFabp7CreER2 _RMaruoka et al., 2011PCR primersGACCGACGATGCATGTTTAGCTGG
Sequence-based reagentGt(ROSA)26Sortm1(DTA)Jpmb/J _FThe Jackson LaboratoryPCR primersAAAGTCGCTCTGAGTTGTTAT
Sequence-based reagentGt(ROSA)26Sortm1(DTA)Jpmb/J _RThe Jackson LaboratoryPCR primersGCGAAGAGTTTGTCCTCACC
Sequence-based reagentB6.129-Kcnj10tm1Kdmc/J _FThe Jackson LaboratoryPCR primersTGATCTATCTCGATTGCTGC
Sequence-based reagentB6.129-Kcnj10tm1Kdmc/J _RThe Jackson LaboratoryPCR primersCCCTACTCAATGCTCTTAAC
Sequence-based reagentGt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_WT FThe Jackson LaboratoryPCR primersGGC TTA AAG GCT AAC CTG ATG TG
Sequence-based reagentGt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_WT RThe Jackson LaboratoryPCR primersGGA GCG GGA GAA ATG GAT ATG
Sequence-based reagentGt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_Mut FThe Jackson LaboratoryPCR primersCCG GAT TGA TGG TAG TGG TC
Sequence-based reagentGt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo_Mut RThe Jackson LaboratoryPCR primersAAT CCA TCT TGT TCA ATG GCC GAT C
Chemical compound, drugHydrogen peroxide solution, 30% in H2O, ACS reagentSigma-AldrichCat# 216763
Chemical compound, drugSIGMAFAST 3,3'-Diaminobenzidine tablets, tablet, to prepare 15 mLSigma-AldrichCat# D4418-50SET
Chemical compound, drug6-Hydrodroxydopamine hydrobromideHello BioCat# HB1889
Chemical compound, drugHematoxylin solutionSigma-AldrichCat# GHS232
Chemical compound, drugBouin’s solutionSigma-AldrichCat# HT10132-1L
Chemical compound, drugGlycogenThermo FisherCat# R0551
Chemical compound, drugMaxima SYBR Green/ROX qPCR Master Mix (2×)Thermo FisherCat# K0222
Chemical compound, drugTaqMan Universal PCR Master MixThermo FisherCat# 4304437
Chemical compound, drugTrizolThermo FisherCat# 15596018
OtherDAPIRocheCat# 10236276001(1 µg/mL)
Chemical compound, drugAgarose, low EEOSigmaCat# A0576-25G
Chemical compound, drugProLong Gold Antifade MountantThermo FisherCat# P36930
Chemical compound, drugPermount Mounting MediaFisher ScientificCat# SP11500
Chemical compound, drugFlouromount Mounting MediaSigma-AldrichCat# F4680-25mL
Commercial assay or kitClick-iT EdU Alexa Fluor 555 Imaging KitLife TechnologiesCat# 10338
Commercial assay or kitIn Situ Cell Death Detection Kit, TMR redRocheCat# 12156792910
Commercial assay or kitNorepinephrine Research ELISARocky Mountain Diagnostics, IncBA E-5200
Commercial assay or kitSuperscript IV First Strand Synthesis SystemThermo FisherCat# 18091050
Commercial assay or kitAgilent Absolutely RNA Nanoprep KitAgilentCat# 400753
Commercial assay or kitRNAscope Fluorescent Multiplex AssayACDCat# 320850
Commercial assay or kitRNAscope Probe-Kcnj10-C3ACDCat# 458831-C3
Software, algorithmLabChart 8 software (ADInstruments)N/Ahttps://www.adinstruments.com/support/software
Software, algorithmImageJN/Ahttps://imagej.nih.gov/ij/
Software, algorithmZEN 2012 SP1 (black edition)N/Ahttps://www.zeiss.com/microscopy/int/home.html
Software, algorithmZEN 2012 (blue edition)N/Ahttps://www.zeiss.com/microscopy/int/home.html

Animal care and housing

Request a detailed protocol

All procedures relating to animal care and treatment conformed to The Johns Hopkins University Animal Care and Use Committee (ACUC) and NIH guidelines. Animals were group housed in a standard 12:12 light–dark cycle, except for the pupil analyses. Adult mice between 1 and 1.5 months of age, and of both sexes, were used for analyses. The following mouse lines were used in this study: C57Bl/6J (JAX:000664) mice, Fabp7-CreER2 mice (Maruoka et al., 2011) were generously provided by Dr. Toshihiko Hosoya (RIKEN Brain Science Institute), Kcnj10fl/fl mice (Djukic et al., 2007) (The Jackson Laboratory, stock no: 026826) by Dr. Dwight Bergles (Johns Hopkins School of Medicine), and ROSA26mEGFP mice (Muzumdar et al., 2007) (The Jackson Laboratory, stock no: 007576) by Dr. David Linden (Johns Hopkins School of Medicine). ROSA26eGFP-DTA mice were obtained from The Jackson Laboratory (stock no: 006331).

Tamoxifen injections

Request a detailed protocol

At postnatal day 30, C57Bl/6J, Fabp7-CreER2;ROSA26mEGFP, Fabp7-CreER2;ROSA26eGFP-DTA, or Fabp7-CreER2;Kcnj10fl/fl mice were injected subcutaneously with either vehicle corn oil (Sigma) or tamoxifen (180 mg/kg body weight) dissolved in corn oil for five consecutive days. All analyses were performed at 5 or 14 days after the last injection.

Quantitative PCR

Request a detailed protocol

RNA was isolated from dissected SCGs or cardiac tissue using Absolutely RNA Nanoprep Kit (Agilent) or Trizol-chloroform extraction. cDNA was prepared using Superscript IV First Strand Synthesis System. Real-time qPCR analysis was performed using Maxima SYBER Green/Rox Q-PCR Master Mix (Thermo Fisher) and gene-specific primers for SCG tissues or TaqMan probes for adrenergic receptors in heart tissue, in a 7300 Real time PCR System (Applied Biosystems). Each sample was analyzed in triplicate reactions. Fold change was calculated using the 2(ΔΔCt) method, normalizing to 18S transcript.

Single-molecule fluorescence in situ hybridization

Request a detailed protocol

SCGs were dissected from P48 mice, cryoprotected in 30% sucrose in PBS for 1 hr and embedded in OCT and frozen at –80°C. Ganglia were cryosectioned at 14 µm and kept at –80°C until smFISH was performed. Target mRNA was probed using RNAscope Multiplex Fluorescent Reagent Kit v2 Assay. Tissues were incubated in fresh 4% paraformaldehyde for 5 min, washed twice in 1× PBS, and dehydrated with increasing concentrations of ethanol. Subsequently, tissues were treated with hydrogen peroxide for 10 min and protease treatment for 15 min. RNAscope assays were performed following the manufacturer’s instructions. Tissues were mounted with Prolong Anti-fade Mounting Media and imaged using a Zeiss LSM 800 confocal microscope.

Immunohistochemical analyses

Request a detailed protocol

SCGs were harvested and incubated in 4% paraformaldehyde for 4 hr at room temperature, cryoprotected in 30% sucrose in 1× PBS for 3 days, embedded in OCT (Sakura Finetek) and stored at –80°C. Ganglia were cryosectioned at 12–30 μm sections for immunohistochemistry. For paraffin embedding, SCGs were fixed in Bouin’s solution for 1 hr at room temperature, left in 70% ethanol overnight at room temperature, followed by consecutive washes in 70, 80, 95, and 100% ethanol, and xylene. Tissues were embedded in paraffin wax and sectioned at 6 µm using a microtome, and rehydrated using a series of xylene and ethanol washes at room temperature. Tissue sections were permeabilized in 0.1% Triton X-100 in 1× PBS at room temperature 3× for 5 min each, followed by incubation in 10 mM sodium citrate buffer (pH 6) at 95°C for 10 min. Tissues were blocked in 5% goat serum/3% bovine serum albumin in 0.1% or 0.3% Triton X-100 in 1× PBS (blocking solution) for 1 hr at room temperature. Primary antibodies used were mouse anti-BLBP (1:500), rabbit anti-BLBP (1:200), mouse anti-TH (1:300), rabbit anti-TH (1:300), rabbit anti-TrkA (1:200), rabbit anti-IBA1 (1:200), rabbit anti-pS6 (1:200), rabbit anti-p4E-BP1 (1:200), rabbit anti-c-Fos (1:1000), goat anti-Sox10 (1:50), or rabbit anti-Kir4.1 (1:100) with incubations performed overnight at 4°C. Slides were washed in blocking solution and then incubated in Alexa-488 ,-546, or-647 conjugated anti-rabbit or anti-mouse secondary antibodies (1:200 dilution) and DAPI (1:1000) in blocking buffer. Tissues were then mounted in Aqueous Mounting Medium and imaged at 1 µm optical slices using a Zeiss LSM 700 or LSM 800 confocal microscope. Maximum intensity projections and maximum intensity 3D projections were generated using ImageJ.

For Sox-2 immunostaining, SCGs were embedded in 3% agarose (Sigma) and sectioned at 100-µm-thick sections using a vibratome. Tissues were permeabilized/blocked in 10% goat serum/3% tween in 1× PBS for 2 hr at room temperature, incubated with rabbit anti-Sox2 (1:500) and mouse anti-TH (1:300) antibodies in blocking solution for 2 days at 4°C, followed by Alexa-546 or -647 conjugated anti-rabbit or anti-mouse secondary antibodies (1:400 dilution) and DAPI (1:1000). Maximum intensity 3D projections were generated using ImageJ.

Binary images of Sox2+ cells were generated using Fourier Bandpass Filter plug-in on ImageJ to first reduce edge artifacts, and then adjusting the threshold to the maximum fluorescence intensity of 255 nm. Particles of sizes between 3 and 50 μm were quantified using the ‘Analyze Particle’ plug-in on ImageJ.

For TH DAB immunohistochemistry, paraffin sections (6 μm) of SCGs were prepared as described above. After tissues were rehydrated, peroxidase quenching was done by incubation in a tris buffer solution (TBS) containing 3% hydrogen peroxide/5% methanol for 15 min at room temperature. Tissues were then permeabilized/blocked in 10% donkey serum/1% glycine/2% bovine serum albumin/0.4% Triton X-100 in 1× TBS for 2 hr at room temperature, incubated with rabbit anti-TH (1:200) in blocking solution overnight at 4°C. Slides were washed three times with TBS, incubated with rabbit anti-HRP in blocking solution for 1 hr at room temperature, washed with TBS before being incubated with SIGMAFAST 3,3'-diaminobenzidine for 10 min. Tissues were washed once with TBS and counterstained with hematoxylin for 1 min prior to dehydrating in increasing concentrations of ethanol and xylene. Tissues were mounted with Permount Mounting Media. Glial nuclei associated with TH-positive neurons in SCGs were counted using ImageJ.

iDISCO and wholemount immunostaining

Request a detailed protocol

iDISCO-based tissue clearing for wholemount immunostaining of organs from P48 mice was performed as previously described (Renier et al., 2014). Briefly, hearts were fixed in 4% PFA/PBS, then dehydrated by methanol series (20–80%) and incubated overnight in 66% dichloromethane (DCM)/33% methanol. Samples were then bleached with 5% H2O2 in methanol at 4°C overnight, then re-hydrated and permeabilized first with 0.2% Triton X-100 followed by overnight permeabilization with 0.16% Triton X-100/20% DMSO/0.3 M glycine in PBS. Samples were incubated in blocking solution (0.17% Triton X-100/10% DMSO/6% Normal Goat Serum in PBS) for 8 hr, and then incubated with rabbit anti-TH (1:400) in 0.2% Tween-20/0.001% heparin/5% DMSO/3% Normal Goat Serum in PBS at 37°C for 96 hr. Samples were then washed with 0.2% Tween-20/0.001% heparin in PBS and incubated with anti-rabbit Alexa-546 secondary antibody (1:400) in 0.2% Tween-20/0.001% heparin/3% Normal Goat Serum in PBS. After 96 hr, organs were extensively washed with 0.2% Tween-20/0.001% heparin in PBS and dehydrated in methanol. Samples were cleared by successive washes in 66% DCM/33% methanol, 100% DCM, and 100% dibenzyl ether. Organs were imaged on a lightsheet microscope (LaVision BioTec Ultra Microscope II). Imaris was used for 3D manipulations. Total axon lengths and number of branch points were quantified using Imaris Filament Tracer and normalized to total organ volume.

Soma size

Request a detailed protocol

SCG tissue sections were labeled with hematoxylin and eosin. Cells with characteristic neuronal morphology and visible nucleoli were identified, soma were traced and areas (µm2) quantified using ImageJ (Fiji).

Neuronal cell counts

Request a detailed protocol

Neuronal counts were performed as previously described (Scott-Solomon and Kuruvilla, 2020). In brief, torsos of P39-48 mice were fixed in 4% PFA/PBS overnight and cryoprotected in 30% sucrose/PBS for 48 hr. Torsos were then mounted in OCT and serially sectioned (12 μm). Next, every fifth section was stained with solution containing 0.5% cresyl violet (Nissl). Cells in both SCGs with characteristic neuronal morphology and visible nucleoli were counted using ImageJ.

TUNEL

Request a detailed protocol

Apoptotic cells were identified in every fifth section of ganglia. Tissues were first incubated with primary and secondary antibodies as described above, followed by detection of cell death using TUNEL staining (Roche) according to the manufacturer’s protocol. Cells that were double positive for DAPI and TUNEL were counted as dying cells. To quantify neuronal or glial apoptosis, TUNEL labeling was done together with TrkA or Sox10 immunostaining as described above. TUNEL+; TrkA+ and TUNEL+; Sox10+ cells were expressed as percentages of the total number of TrkA+ and Sox 10+ cells, respectively.

EdU labeling

Request a detailed protocol

Tamoxifen- or corn oil-injected adult mice were injected intraperitoneally with EdU (Invitrogen, 100 µg/ml in 3:1 PBS/DMSO) for five consecutive days before harvesting at 5 days post-tamoxifen injections. SCG tissue sections (12 μm) were processed for 30 min at room temperature in EdU reaction cocktail (Thermo Fisher EdU kit C10337; Click-iT buffer, Buffer additive, CuSO4 solution, and Alexa Fluor 488). Sections were then washed in PBS +0.1% Triton X-100 and mounted with Fluoromount + DAPI. Images were collected using a Zeiss LSM 700 confocal microscope. The total number of cells that incorporated EdU in each section was counted and summed for an entire SCG.

Norepinephrine ELISA

Request a detailed protocol

Blood samples drawn from anesthetized mice were centrifuged for 15 min, 3000 rpm in 0.5 M EDTA-coated tubes at 4°C. NE levels in plasma (300 μl) was assessed using a ELISA kit (Abnova) according to the manufacturer’s protocol.

Pupil analyses

Request a detailed protocol

Pupil size measurements were performed as reported previously (Keenan et al., 2016). Briefly, all mice were dark-adapted and housed in single cages for 2 days and analyzed in the evenings. For all experiments, mice were unanesthetized and restrained by hand. To mitigate stress, which can affect pupil size, researchers handled mice for several days prior to the measurements. Videos of the eye were recorded for 5–10 s in the dark using a Sony Handycam (DCR-HC96) mounted on a tripod at a fixed distance from the mouse. Manual focus was maintained on the camera to ensure that only one focal plane existed for each mouse. Pupil size was recorded under dim red light and the endogenous infrared light source of the camera to capture the basal pupil size.

To examine parasympathetic activity, mice were dark-adapted for 2 days. Unanesthetized mice were restrained by hand. Pupil size was recorded first for 5–10 s in the dark followed by a 30 s exposure to a light step stimulus. The light stimulus was provided by 10 W or 14 W LED bulbs (Sunlite A19/or Sunlite 80599-SU LED A19 Super Bright Light Bulb, Daylight). Light intensity was measured using a light meter (EXTECH Foot Candle/Lux Light Meter, 401025) at the surface on which the mouse was held. Light intensity was adjusted by a combination of altering the distance of the light bulb from the mouse and/or applying neutral density filters (Roscolux). The light meter is unreliable at detecting light intensities below 1 lux, so one neutral density filter cutting the light intensity by 12.5% was applied to the bulb to estimate 1-log unit decreases in illumination below 1 lux. Light intensities above 500 lux required the use of multiple light bulbs.

Electrocardiograms

Request a detailed protocol

ECG recordings were performed on adult mice as previously described (Ståhlberg et al., 2019). Briefly, adult mice (P39-48) were anesthetized with 4% isoflurane, intubated, and placed on ventilator support (settings 1.2 ml/g/min at 80 breaths/min). The animal’s dorsum was shaved, scrubbed with betadine and alcohol, and draped with a sterile barrier with the surgery site exposed. A small 0.5 cm midline incision was performed and ECG leads were implanted subcutaneously and sutured over the trapezius muscle on both sides. Body temperature was maintained at 37°C. Immediately following implantation, the wound was closed with a 3-0 silk suture. Anesthesia was turned off and the animal was monitored for spontaneous breathing and was given a subcutaneous buprenorphine injection (0.01–0.05 mg/kg buprenorphine, IM) to alleviate pain. ECGs were subsequently recorded continuously in conscious animals for approximately 7 days for each mouse using the Powerlab data acquisition device and LabChart 8 software (ADInstruments). Mice were kept at a stable temperature with regular 12 hr light/dark cycle. To exclude the effects of pain and anesthesia, continuous ECG recordings between day 4 and 7 post-lead implantation were only included in the analysis of mean heart rates. HRV was analyzed using LabChart 8 and at 10–12 hr intervals as previously described (Thireau et al., 2008).

To assess effects of tamoxifen alone, adult (P39-48) C57Bl/6J or ROSA26eGFP-DTA mice that did not express Cre mice were injected with corn oil or tamoxifen (subcutaneous injections, 180 mg/kg body weight for five consecutive days) and ECGs recorded as described above.

6-OHDA injections

Request a detailed protocol

For chemical ablation of sympathetic nerves, Fabp7-CreER2;ROSA26eGFP-DTA mice were first injected with corn oil or tamoxifen. After 18–20 days, control and BLBP:iDTA mice received two intraperitoneal injections, 3 days apart, of 6-OHDA (150 mg/kg) dissolved in 0.1% ascorbic acid. ECGs were subsequently recorded continuously in conscious animals for approximately 4 days for each mouse as described above.

Quantification and statistical analyses

Request a detailed protocol

Sample sizes in this study were calculated using power analyses using RStudio statistical software. For practical reasons, analyses of innervation, cell death assays, proliferation assays, soma size measurements, and NE ELISA’s were performed in a semi-blinded manner. The experimenter was aware of the genotypes but performed each immunostaining and measurements without knowing the genotypes. All physiological experiments (pupil dilation and HRV) were performed in a blinded manner; the experimenter was only aware of the ear tag numbers. All t-tests were performed assuming Gaussian distribution, two-tailed, unpaired, and a confidence interval of 95%. One-way or two-way ANOVA with Bonferroni’s correction were performed when more than two groups were compared. All error bars represent the standard error of the mean (SEM).

Data availability

All data generated or analysed during this study are included in the manuscript (Results, Materials and Methods, and Figure Legends).

References

    1. Fagan AM
    2. Zhang H
    3. Landis S
    4. Smeyne RJ
    5. Silos-Santiago I
    6. Barbacid M
    (1996)
    TrkA, but not trkc, receptors are essential for survival of sympathetic neurons in vivo
    The Journal of Neuroscience 16:6208–6218.
    1. Kostrzewa RM
    2. Jacobowitz DM
    (1974)
    Pharmacological actions of 6-hydroxydopamine
    Pharmacological Reviews 26:199–288.
  70. Conference
    1. Pannese E
    (1981)
    The satellite cells of the sensory ganglia
    Advances in Anatomy, Embryology, and Cell Biology.
    1. Tsui-Pierchala BA
    2. Ginty DD
    (1999)
    Characterization of an NGF-P-trka retrograde-signaling complex and age-dependent regulation of trka phosphorylation in sympathetic neurons
    The Journal of Neuroscience 19:8207–8218.

Article and author information

Author details

  1. Aurelia A Mapps

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Contribution
    Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7956-2465

  2. Erica Boehm

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Contribution
    Methodology
    Competing interests
    No competing interests declared

  3. Corinne Beier

    Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health, Bethesda, United States
    Contribution
    Methodology
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0698-7219

  4. William T Keenan

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Present address
    Department of Neuroscience, The Scripps Research Institute, California, United States
    Contribution
    Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  5. Jennifer Langel

    Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health, Bethesda, United States
    Contribution
    Methodology
    Competing interests
    No competing interests declared

  6. Michael Liu

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Contribution
    Investigation
    Competing interests
    No competing interests declared

  7. Michael B Thomsen

    Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health, Bethesda, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared

  8. Samer Hattar

    Section on Light and Circadian Rhythms (SLCR), National Institute of Mental Health, Bethesda, United States
    Contribution
    Resources, Funding acquisition, Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3124-9525

  9. Haiqing Zhao

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Contribution
    Resources, Funding acquisition, Project administration, Writing – review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4275-9843

  10. Emmanouil Tampakakis

    Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, United States
    Contribution
    Investigation, Methodology, Writing – review and editing
    Competing interests
    No competing interests declared

  11. Rejji Kuruvilla

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Contribution
    Conceptualization, Resources, Funding acquisition, Writing - original draft, Project administration, Writing – review and editing
    For correspondence
    rkuruvilla@jhu.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2851-675X

Funding

National Institutes of Health (NS073751)

  • Rejji Kuruvilla

National Institutes of Health (NS107342)

  • Rejji Kuruvilla

National Science Foundation (DGE-1746891)

  • Aurelia A Mapps

National Institutes of Health (DC016065)

  • Haiqing Zhao

National Institutes of Health (EY027202)

  • Haiqing Zhao

National Institutes of Health (ZIAMH002964)

  • Samer Hattar

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank all members of the Kuruvilla, Zhao, and Hattar labs for helpful comments on the project. This work was supported by NIH R01 awards, NS073751 and NS107342, to RK, DC016065 and EY027202 to HZ, NIMH intramural research funds (ZIAMH002964) to SH, a NSF GRFP (DGE-1746891) award to AM, and NIH Training grant T32GM007231 to the JHU CMDB graduate program for AM and EB.

Ethics

All procedures relating to animal care and treatment conformed to The Johns Hopkins University Animal Care and Use Committee (ACUC, protocol#MO19A488) and NIH guidelines.

Version history

  1. Preprint posted: September 23, 2021 (view preprint)
  2. Received: September 28, 2021
  3. Accepted: August 22, 2022
  4. Accepted Manuscript published: August 23, 2022 (version 1)
  5. Accepted Manuscript updated: August 25, 2022 (version 2)
  6. Version of Record published: August 31, 2022 (version 3)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 1,497
    views
  • 400
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Aurelia A Mapps
  2. Erica Boehm
  3. Corinne Beier
  4. William T Keenan
  5. Jennifer Langel
  6. Michael Liu
  7. Michael B Thomsen
  8. Samer Hattar
  9. Haiqing Zhao
  10. Emmanouil Tampakakis
  11. Rejji Kuruvilla
(2022)
Satellite glia modulate sympathetic neuron survival, activity, and autonomic function
eLife 11:e74295.
https://doi.org/10.7554/eLife.74295

Share this article

https://doi.org/10.7554/eLife.74295

Categories and tags

Research organism

Further reading

    1. Cell Biology
    2. Neuroscience

    KIS counteracts PTBP2 and regulates alternative exon usage in neurons

    Marcos Moreno-Aguilera, Alba M Neher ... Carme Gallego
    Research Article Updated

    Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.

    1. Genetics and Genomics
    2. Neuroscience

    Genetic Chimerism: Marmosets contain multitudes

    Kenneth Chiou, Noah Snyder-Mackler
    Insight

    Single-cell RNA sequencing reveals the extent to which marmosets carry genetically distinct cells from their siblings.

    1. Neuroscience

    Episodic long-term memory formation during slow-wave sleep

    Flavio J Schmidig, Simon Ruch, Katharina Henke
    Research Article

    We are unresponsive during slow-wave sleep but continue monitoring external events for survival. Our brain wakens us when danger is imminent. If events are non-threatening, our brain might store them for later consideration to improve decision-making. To test this hypothesis, we examined whether novel vocabulary consisting of simultaneously played pseudowords and translation words are encoded/stored during sleep, and which neural-electrical events facilitate encoding/storage. An algorithm for brain-state-dependent stimulation selectively targeted word pairs to slow-wave peaks or troughs. Retrieval tests were given 12 and 36 hr later. These tests required decisions regarding the semantic category of previously sleep-played pseudowords. The sleep-played vocabulary influenced awake decision-making 36 hr later, if targeted to troughs. The words’ linguistic processing raised neural complexity. The words’ semantic-associative encoding was supported by increased theta power during the ensuing peak. Fast-spindle power ramped up during a second peak likely aiding consolidation. Hence, new vocabulary played during slow-wave sleep was stored and influenced decision-making days later.